Related Experiment Video
Updated: Oct 16, 2025
Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Effectiveness of a screening program for HBV, HCV, and HIV infections in African migrants to Sicily
Tullio Prestileo1, Vito Di Marco2, Ornella Dino3
1Infectious Diseases Unit & Centre for Migration and Health, ARNAS Civico-Benfratelli Hospital, Palermo, Italy; Immigrant Take Care Advocacy (ITaCA), Palermo, Italy; Centro Interdipartimentale Ricerca Migrare, University of Palermo, Italy.
Background:
Migrants from Africa are vulnerable to viral infections during their journey.
Methods:
Migrants who arrived in western Sicily were offered early screening for hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infection. A questionnaire was administered to evaluate risk factors, and antiviral therapy was offered to subjects with active infection. A multiple regression analysis and adjusted odds ratio were obtained to evaluate risk factors.
Results:
Overall, 2,639 of 2,751 (95.9%) migrants who arrived between 2015 and 2017 accepted screening and 1,911 (72.4%) completed the questionnaire. HBsAg was positive in 257 (9.7%) migrants, 24 (0.9%) were anti-HCV positive and 57 (2.2%) had HIV infection. The prevalence of HBV infection was higher in women (aOR 2.47,95%CI 1.90-3.20),p = 0.003) and in people who endured physical and/or sexual violence (aOR 2.24,95%CI 1.87-3.55,p<0.001), while HIV infection was more frequent in women (aOR 5.40,95%CI 3.09-9.43, p <0.001) who were in Libya for a long period (aOR 5.66,95%CI 2.90-10.70,p = 0.004) and endured physical and/or sexual violence (aOR 14.77,95%CI 8.34-22.11,p<0.001). Being older than 18 was associated with HCV infection (p<0.001). Overall, 77% of 57 subjects with HIV infection were retained in care, 79% of 70 chronic HBV hepatitis cases started nucleot(s)ide analogues and 61% of 18 HCV-RNA positive cases received direct-acting antiviral therapy.
Conclusions:
These findings evidence the effectiveness and feasibility of infectious disease screening programs for migrants.
